Drug Channels
APRIL 8, 2024
This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system.
European Pharmaceutical Review
NOVEMBER 10, 2023
The construction projects will be finalised from the end of 2025 through to 2029. Novo Nordisk’s Denmark manufacturing facilities Currently, Novo Nordisk’s Kalundborg production facilities manufacture products for treating obesity and diabetes as well as several biopharmaceutical products, employing around 4,400 employees.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 17, 2022
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.
European Pharmaceutical Review
SEPTEMBER 14, 2023
Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e). Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.
European Pharmaceutical Review
SEPTEMBER 26, 2022
AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.
Express Pharma
MARCH 12, 2024
300 crore, over the next two fiscal years (150 units each in 2024-25 and 2025-26). The intended beneficiaries are now specified as existing pharmaceutical manufacturing units with an average turnover of less than Rs. ” The revised scheme is expected to support 300 units, with a total outlay of Rs.
Quality Matters
APRIL 19, 2024
By 2025, PEPFAR aims to procure 15 million HIV tests from African manufacturers. However, this is still largely an exception across the continent and most countries do not have the manufacturing capability to meet regional or national demands to realize PEPFAR’s goals. But PEPFAR is looking to change how it does business.
Expert insights. Personalized for you.
73 
Let's personalize your content